Format

Send to

Choose Destination
See comment in PubMed Commons below
Target Oncol. 2009 Jan;4(1):45-56. doi: 10.1007/s11523-008-0101-x. Epub 2009 Jan 27.

Imatinib in the treatment of solid tumours.

Author information

  • 1Hôpital La timone, Centre Hospitalier Universitaire de l'Assistance Publique des Hôpitaux de Marseille, 264 rue Saint Pierre, 13385, Marseille, France. florence.duffaud@mail.ap-hm.fr

Abstract

The extraordinary success of imatinib in gastrointestinal stromal tumors (GIST) represents a model for molecularly targeted therapy for other solid tumors. Research is currently going to identify the molecular basis of mechanisms of action and drug resistance. In this article, we review recent advances in the clinical management of patients with GISTs treated with imatinib, but also of patients with dermatofibrosarcoma protuberans, chordoma, aggressive fibromatosis, and some other common solid tumors treated with this drug. We reviewed the knowledge of the molecular mechanisms that are basic to imatinib effects in these tumors.

PMID:
19343301
DOI:
10.1007/s11523-008-0101-x
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Springer
    Loading ...
    Support Center